Macrogen Future Growth
Future criteria checks 4/6
Macrogen is forecast to grow earnings and revenue by 108.1% and 15.6% per annum respectively. EPS is expected to grow by 109.3% per annum. Return on equity is forecast to be 7.8% in 3 years.
Key information
108.1%
Earnings growth rate
109.3%
EPS growth rate
Life Sciences earnings growth | 28.4% |
Revenue growth rate | 15.6% |
Future return on equity | 7.8% |
Analyst coverage | Low |
Last updated | 24 Jun 2024 |
Recent future growth updates
Recent updates
Macrogen, Inc.'s (KOSDAQ:038290) Revenues Are Not Doing Enough For Some Investors
Jul 24Macrogen's (KOSDAQ:038290) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 02Macrogen (KOSDAQ:038290) Has Debt But No Earnings; Should You Worry?
Mar 03Reflecting on Macrogen's (KOSDAQ:038290) Share Price Returns Over The Last Three Years
Jan 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 191,000 | 15,000 | 9,000 | 48,000 | 1 |
12/31/2025 | 158,900 | 12,100 | N/A | 42,000 | 1 |
12/31/2024 | 137,000 | -2,100 | -5,000 | 33,000 | 1 |
6/30/2024 | 131,018 | -20,478 | -20,087 | 7,269 | N/A |
3/31/2024 | 131,009 | -20,395 | -22,822 | 6,895 | N/A |
12/31/2023 | 132,803 | -16,814 | -19,582 | 4,765 | N/A |
9/30/2023 | 133,923 | -22,200 | -13,879 | 6,858 | N/A |
6/30/2023 | 137,180 | -18,692 | -11,729 | 9,961 | N/A |
3/31/2023 | 136,765 | -20,892 | -10,018 | 9,504 | N/A |
12/31/2022 | 138,617 | -22,253 | -9,017 | 10,767 | N/A |
9/30/2022 | 137,850 | 2,257 | -11,180 | 8,652 | N/A |
6/30/2022 | 130,775 | 872 | -4,578 | 9,661 | N/A |
3/31/2022 | 130,268 | 4,212 | 3,260 | 14,207 | N/A |
12/31/2021 | 129,175 | 1,112 | 11,308 | 21,127 | N/A |
9/30/2021 | 125,233 | -12,321 | 22,798 | 28,423 | N/A |
6/30/2021 | 123,962 | 1,299 | 22,220 | 31,255 | N/A |
3/31/2021 | 118,037 | 213 | 14,106 | 27,519 | N/A |
12/31/2020 | 112,603 | 4,267 | 1,204 | 20,553 | N/A |
9/30/2020 | 95,787 | 19,627 | -23,834 | 12,406 | N/A |
6/30/2020 | 98,483 | 4,341 | -18,996 | 12,977 | N/A |
3/31/2020 | 101,852 | 10,527 | -56,385 | 17,073 | N/A |
12/31/2019 | 102,815 | 17,892 | -56,489 | 14,496 | N/A |
9/30/2019 | 120,208 | 12,059 | -36,810 | 19,808 | N/A |
6/30/2019 | 115,150 | 12,488 | -41,080 | 17,279 | N/A |
3/31/2019 | 115,639 | 9,104 | -3,573 | 8,259 | N/A |
12/31/2018 | 112,831 | 2,645 | 8,390 | 15,607 | N/A |
9/30/2018 | 108,575 | 12,550 | 3,911 | 11,142 | N/A |
6/30/2018 | 107,959 | 13,228 | 4,321 | 12,401 | N/A |
3/31/2018 | 104,462 | 14,173 | N/A | 12,911 | N/A |
12/31/2017 | 101,793 | 9,529 | N/A | 13,067 | N/A |
9/30/2017 | 98,472 | 1,661 | N/A | 9,372 | N/A |
6/30/2017 | 94,772 | -558 | N/A | 13,294 | N/A |
3/31/2017 | 92,395 | 6 | N/A | 17,360 | N/A |
12/31/2016 | 91,113 | 4,301 | N/A | 21,247 | N/A |
9/30/2016 | 88,207 | 7,049 | N/A | 17,092 | N/A |
6/30/2016 | 90,663 | 11,895 | N/A | 13,535 | N/A |
3/31/2016 | 87,030 | 11,508 | N/A | 7,985 | N/A |
12/31/2015 | 79,534 | 10,172 | N/A | 7,155 | N/A |
9/30/2015 | 73,926 | 4,746 | N/A | 6,998 | N/A |
6/30/2015 | 63,116 | 2,812 | N/A | 3,607 | N/A |
3/31/2015 | 58,090 | 2,435 | N/A | 8,026 | N/A |
12/31/2014 | 54,130 | 2,989 | N/A | 6,770 | N/A |
9/30/2014 | 50,107 | 5,431 | N/A | 7,803 | N/A |
6/30/2014 | 48,688 | 5,641 | N/A | 10,203 | N/A |
3/31/2014 | 48,437 | 6,437 | N/A | 10,164 | N/A |
12/31/2013 | 48,078 | 6,426 | N/A | 9,165 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A038290 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: A038290 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A038290 is expected to become profitable in the next 3 years.
Revenue vs Market: A038290's revenue (15.6% per year) is forecast to grow faster than the KR market (9.9% per year).
High Growth Revenue: A038290's revenue (15.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A038290's Return on Equity is forecast to be low in 3 years time (7.8%).